Shanghai - Delayed Quote CNY
Shanghai Rendu Biotechnology Co., Ltd. (688193.SS)
38.00
+1.00
+(2.70%)
At close: 3:00:04 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
173,221.18
177,351.53
164,412.27
303,848.69
292,306.25
Cost of Revenue
37,154.16
36,380.05
30,817.72
104,740.50
74,178.62
Gross Profit
136,067.03
140,971.48
133,594.55
199,108.18
218,127.63
Operating Expense
150,358.87
153,066.04
141,916.50
180,160.96
148,090.96
Operating Income
-14,291.84
-12,094.56
-8,321.95
18,947.22
70,036.67
Net Non Operating Interest Income Expense
3,745.48
6,240.18
8,258.34
3,838.08
1,678.78
Pretax Income
-18,039.99
-15,221.51
4,762.53
26,681.52
72,441.55
Tax Provision
-7,744.83
-7,409.32
-3,496.77
3,350.12
7,822.66
Net Income Common Stockholders
-10,295.16
-7,812.19
8,259.30
23,331.39
64,618.88
Basic EPS
-0.26
-0.20
0.21
0.62
2.15
Diluted EPS
-0.26
-0.20
0.21
0.61
2.13
Basic Average Shares
38,946.73
39,060.94
39,329.98
37,631.28
30,055.29
Diluted Average Shares
38,946.73
39,060.94
34,413.74
38,248.19
30,337.50
Total Operating Income as Reported
-17,274.87
-14,584.89
5,442.21
27,507.14
72,187.89
Rent Expense Supplemental
--
964.31
486.82
928.12
847.37
Total Expenses
187,513.03
189,446.09
172,734.23
284,901.46
222,269.58
Net Income from Continuing & Discontinued Operation
-10,295.16
-7,812.19
8,259.30
23,331.39
64,618.88
Normalized Income
1,018.15
7,105.81
9,232.35
26,988.91
65,101.34
Interest Income
4,511.49
6,581.68
8,724.87
4,231.71
1,992.98
Interest Expense
249.74
290.93
431.20
355.47
261.71
Net Interest Income
3,745.48
6,240.18
8,258.34
3,838.08
1,678.78
EBIT
-17,790.25
-14,930.58
5,193.73
27,036.99
72,703.25
EBITDA
-17,790.25
2,189.22
20,980.42
41,705.52
82,923.92
Reconciled Cost of Revenue
37,154.16
36,380.05
30,817.72
104,740.50
74,178.62
Reconciled Depreciation
--
17,119.80
15,786.69
14,668.53
10,220.67
Net Income from Continuing Operation Net Minority Interest
-10,295.16
-7,812.19
8,259.30
23,331.39
64,618.88
Total Unusual Items Excluding Goodwill
-18,855.52
-19,890.66
-1,297.41
-4,182.69
-540.86
Total Unusual Items
-18,855.52
-19,890.66
-1,297.41
-4,182.69
-540.86
Normalized EBITDA
1,065.27
22,079.88
22,277.83
45,888.22
83,464.78
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-7,542.21
-4,972.67
-324.35
-525.18
-58.41
12/31/2021 - 3/30/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade